{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:51:27Z","timestamp":1789977087409,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/maj.0b013e318277083b","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T12:33:09Z","timestamp":1356957189000},"page":"137-141","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever"],"prefix":"10.1016","volume":"346","author":[{"given":"Akgu","family":"Ozgur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Ozgocmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e318277083b_bb0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/BOR.0b013e3282f1bf4b","article-title":"The spectrum of autoinflammatory diseases: recent bench to bedside observations","volume":"20","author":"Ryan","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrrheum.2010.181","article-title":"Chronic inflammation in FMF: markers, risk factors, outcomes and therapy","volume":"7","author":"Ben-Zvi","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jbspin.2008.08.004","article-title":"Familial Mediterranean Fever: a review for clinical management","volume":"76","author":"Fonnesu","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11926-011-0191-9","article-title":"Familial Mediterranean fever and seronegative arthritis","volume":"13","author":"Akkoc","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10067-008-0980-3","article-title":"The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis","volume":"28","author":"Kasifoglu","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0030","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial Mediterranean Fever in the world","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0035","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00296-006-0188-2","article-title":"Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases","volume":"27","author":"Sayarlioglu","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00431-008-0875-y","article-title":"Sulphasalazine treatment in protracted familial Mediterranean fever arthritis","volume":"168","author":"Bakkaloglu","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0050","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2362.2007.01868.x","article-title":"Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky","volume":"37","author":"Gattringer","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00431-007-0547-3","article-title":"The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever","volume":"167","author":"Calligaris","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-008-0616-6","article-title":"Coexistence of Familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy","volume":"29","author":"Bodur","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.rhu.0000128856.13595.eb","article-title":"Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis","volume":"10","author":"Metyas","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.20920","article-title":"Infliximab therapy in a patient with Familial Mediterranean fever and chronic hip arthritis","volume":"53","author":"Daysal","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0075","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/kel250","article-title":"Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever","volume":"45","author":"Yuksel","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0080","first-page":"435","article-title":"Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever","volume":"24","author":"Sakallioglu","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10067-005-1122-9","article-title":"Familial Mediterranean fever responds well to infliximab: single case experience","volume":"25","author":"Ozgocmen","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0090","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.rhu.0000255772.25658.7c","article-title":"Familial Mediterranean fever successfully treated with etanercept","volume":"13","author":"Mor","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s10067-006-0521-x","article-title":"Tumor necrosis factor blockade in the management of children with orphan diseases","volume":"26","author":"Brik","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2169\/internalmedicine.49.2777","article-title":"Coexistence of familial Mediterranean fever and juvenile idiopathic arthritis with osteoporosis successfully treated with etanercept","volume":"49","author":"Kaya","year":"2010","journal-title":"Intern Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2169\/internalmedicine.46.0064","article-title":"Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever","volume":"46","author":"Nakamura","year":"2007","journal-title":"Intern Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00296-011-1855-5","article-title":"Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial Mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF","volume":"32","author":"Erten","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0120","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00296-011-1853-7","article-title":"Coexistence of Takayasu\u2019s arteritis with familial Mediterranean fever","volume":"32","author":"Zihni","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for Familial Mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment","volume":"17","author":"Bilgen","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-146-11-200706050-00023","article-title":"Treatment of familial Mediterranean fever with anakinra","volume":"146","author":"Belkhir","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0140","first-page":"489","article-title":"Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient","volume":"66","author":"Mitroulis","year":"2008","journal-title":"Neth J Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","article-title":"Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine","volume":"75","author":"Roldan","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0150","article-title":"Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra-case report and review","author":"Hennig","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/gfn646","article-title":"Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation","volume":"24","author":"Moser","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0160","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00296-010-1474-6","article-title":"Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever","volume":"32","author":"Alpay","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10067-009-1279-8","article-title":"Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behcet\u2019s disease","volume":"29","author":"Bilginer","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/TP.0b013e3181d84cc3","article-title":"Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra","volume":"90","author":"Petropoulou","year":"2010","journal-title":"Transplantation"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in Familial Mediterranean fever: a case series and a review of the literature","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0185","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/ard.2010.146878","article-title":"The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis","volume":"70","author":"Mitroulis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0190","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/ndt\/gfr528","article-title":"Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure","volume":"27","author":"Stankovic Stojanovic","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0195","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/rheumatology\/kes021","article-title":"Canakinumab induces remission in a patient with resistant familial Mediterranean fever","volume":"51","author":"Hacihamdioglu","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/s10165-011-0463-2","article-title":"Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature","volume":"21","author":"Ozgocmen","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0205","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0210","first-page":"721","article-title":"Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever","volume":"16","author":"Kiraz","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"pt 2","key":"10.1097\/MAJ.0b013e318277083b_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3210497","article-title":"Interleukin 1-beta-induced protein kinase C-zeta activation is mimicked by exogenous phospholipase D","volume":"321","author":"Limatola","year":"1997","journal-title":"Biochem J"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0225","first-page":"225","article-title":"Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist","volume":"6","author":"Butler","year":"1995","journal-title":"Eur Cytokine Netw"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0230","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/eji.1830250647","article-title":"The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice","volume":"25","author":"Probert","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0235","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states","volume":"7","author":"Urieli-Shoval","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0245","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa065644","article-title":"Eprodisate for the treatment of renal disease in AA amyloidosis","volume":"356","author":"Dember","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0250","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","article-title":"Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists","volume":"118","author":"Fernandez-Nebro","year":"2005","journal-title":"Am J Med"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0255","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2007.083188","article-title":"Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11926-010-0125-y","article-title":"Update on biologic therapy in the management of axial spondyloarthritis","volume":"12","author":"Heldmann","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0270","first-page":"S77","article-title":"Therapeutic approach to familial Mediterranean fever: a review update","volume":"29","author":"Ozturk","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1097\/MAJ.0b013e318277083b_bb0275","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.107.721357","article-title":"Evaluating the evidence: is there a rigid hierarchy?","volume":"118","author":"Ho","year":"2008","journal-title":"Circulation"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T08:20:40Z","timestamp":1687940440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915305747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0002962915305747"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e318277083b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}